Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,601 total articles

LOBO Upgrades Claw AI Platform via “AI Director” Advisory Layer, Advancing to Enterprise-Level Strategic Decision-Making and Closed-Loop AI Agent Ecosystem
Apr 21, 2026
Maya Rios
Press Releases

LOBO Upgrades Claw AI Platform via “AI Director” Advisory Layer, Advancing to Enterprise-Level Strategic Decision-Making and Closed-Loop AI Agent Ecosystem

LOBO TECHNOLOGIES LTD., a Nasdaq-listed electric mobility manufacturer, announced a significant upgrade to its Claw AI Agent Platform by integrating five new AI Directors to provide enterprise-level strategic advisory services. This advancement transforms the platform from operational execution tools into a comprehensive, closed-loop AI ecosystem t…

LOBO
Syntec Optics ("OPTX") Advances Domestic Defense Tech with $2M Foundational Purchase Order for AI-Powered AR Cameras
Apr 21, 2026
Marcus Reed
Press Releases

Syntec Optics ("OPTX") Advances Domestic Defense Tech with $2M Foundational Purchase Order for AI-Powered AR Cameras

Syntec Optics announced a $2 million foundational order for AI-enabled augmented reality micro cameras designed for U.S. military applications, marking an expansion of its defense technology portfolio. The order initiates recurring annual revenue opportunities and leverages Syntec's vertically integrated U.S.-based manufacturing to meet stringent n…

OPTX
Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 21, 2026
Priya Menon
Press Releases

Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Cogent Biosciences announced the oral presentation of positive Phase 3 PEAK trial results combining bezuclastinib and sunitinib for advanced gastrointestinal stromal tumors (GIST) at ASCO 2026. The trial showed promising efficacy in patients previously treated with imatinib. The company has submitted a New Drug Application (NDA) under the FDA's RTO…

COGT
Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology
Apr 21, 2026
Hana Yamamoto
Press Releases

Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology

Glucotrack, Inc. announced the publication of a peer-reviewed study in the IEEE Sensors Journal demonstrating the long-term stability and viability of its implantable continuous blood glucose monitoring sensor technology. The year-long in-vitro study on glucose oxidase enzyme decay supports the feasibility of their long-life (3-year) implantable gl…

GCTK
New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years
Apr 21, 2026
Caleb Monroe
Press Releases

New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years

Smith+Nephew announced new 5-year follow-up data from a multicenter randomized controlled trial demonstrating the clinical superiority of its CARTIHEAL AGILI-C Cartilage Repair Implant over standard surgical care for treating knee cartilage lesions. The implant showed significant improvements in pain relief, knee function, and quality of life, with…

SNN
Calidi Biotherapeutics Presents New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
Apr 21, 2026
Avery Klein
Press Releases

Calidi Biotherapeutics Presents New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026

Calidi Biotherapeutics presented new preclinical data at the AACR 2026 meeting highlighting the effectiveness of its lead candidate CLD-401, a systemically delivered oncolytic virus expressing IL-15 superagonist to activate immune cells specifically within the tumor microenvironment. The data show robust immune activation and therapeutic responses …

CLDI
VisionWave Announces Strategic Investment in Foresight Autonomous Holdings and Integration with xClibre™ AI Video Intelligence
Apr 21, 2026
Sofia Navarro
Press Releases

VisionWave Announces Strategic Investment in Foresight Autonomous Holdings and Integration with xClibre™ AI Video Intelligence

VisionWave Holdings, Inc. announced a strategic investment to acquire up to 51% of Foresight Autonomous Holdings Ltd. by exchanging $17.5 million in VisionWave equity. This follows the recent acquisition of the xClibre AI video intelligence IP portfolio, valued at approximately $60 million. The combined technologies aim to create an integrated mult…

VWAV
LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack
Apr 21, 2026
Priya Menon
Press Releases

LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack

LifeVantage Corporation has been granted a U.S. patent for its Healthy Glow Essentials Stack, a combination of nutritional supplements that activate cellular signaling genes linked to skin health and anti-aging benefits. The patented products include Protandim Nrf2 Synergizer and TrueScience Liquid Collagen, which synergistically promote antioxidan…

LFVN
Allarity Therapeutics Presents Two AACR 2026 Posters Highlighting Stenoparib’s Potential in Colorectal Cancer as well as New Predictive Data Linking DRP® and Overall Survival in Ovarian Cancer
Apr 21, 2026
Marcus Reed
Press Releases

Allarity Therapeutics Presents Two AACR 2026 Posters Highlighting Stenoparib’s Potential in Colorectal Cancer as well as New Predictive Data Linking DRP® and Overall Survival in Ovarian Cancer

Allarity Therapeutics announced the presentation of two scientific posters at AACR 2026, showcasing stenoparib's dual PARP and WNT pathway inhibition in colorectal cancer and its companion diagnostic (DRP®) linked to improved overall survival in ovarian cancer patients. These data underline the drug’s potential as a novel cancer therapeutic and the…

ALLR
Lightbridge to Hold Business Update & First Quarter 2026 Earnings Conference Call on Tuesday, April 28 at 4 p.m. ET
Apr 21, 2026
Caleb Monroe
Press Releases

Lightbridge to Hold Business Update & First Quarter 2026 Earnings Conference Call on Tuesday, April 28 at 4 p.m. ET

Lightbridge Corporation announced it will release its first quarter fiscal 2026 financial results on April 27, 2026, followed by a conference call on April 28 to discuss the results and provide updates on its advanced nuclear fuel technology projects. The company highlights its continued development of next-generation nuclear fuel aimed at improvin…

LTBR
Franklin Electric to Participate in Upcoming Investor Conferences
Apr 21, 2026
Caleb Monroe
Press Releases

Franklin Electric to Participate in Upcoming Investor Conferences

Franklin Electric Co., Inc., a leader in manufacturing systems for water, fuel, and electricity movement and management, announced its CEO and CFO will participate in two upcoming investor conferences in May 2026. The company reiterated its commitment to transparency with live webcasts and recognized the risks related to economic and industry condi…

FELE
Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy
Apr 21, 2026
Priya Menon
Press Releases

Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy

Catheter Precision, Inc. announced that the USPTO has issued a Notice of Allowance for core claims covering its proprietary surgical vessel closing pressure device. This patent protection covers both the device architecture and use method, establishing robust intellectual property barriers in vascular procedural markets. The milestone supports the …

VTAK
Kaltura’s Agentic Avatars Combine With PathFactory to Deliver More Sophisticated Buyer Journeys From First Click to Closed‑Won
Apr 21, 2026
Priya Menon
Press Releases

Kaltura’s Agentic Avatars Combine With PathFactory to Deliver More Sophisticated Buyer Journeys From First Click to Closed‑Won

Kaltura, Inc. announces a limited beta release of a unified conversational AI platform integrating PathFactory's ChatFactory with Kaltura's Agentic Avatars. This solution offers an advanced digital engagement experience across full customer journeys, combining personalized content discovery, AI-driven conversations, and photorealistic avatars for r…

KLTR
Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair
Apr 21, 2026
Nina Shah
Press Releases

Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair

Humacyte announced that the Israeli Ministry of Health has accepted their Marketing Authorization Application for Symvess® (acellular tissue engineered vessel) to treat vascular trauma. The ministry has assigned a 180-working-day review period. This acceptance marks an important step in the company's plan to expand Symvess beyond the U.S., leveragi…

HUMA